BioEurope product launch of rHSA with partner ARTES Biosciences
ARTES Biosciences and Basic Pharma are interested and proud to offer the first commercial samples of our joint recombinant human serum albumin (rHSA) production from yeast (Hansenula polymorpha) for research and development purposes. During BIO-Europe our partner ARTES Biosciences will be available at booth 149 to provide comprehensive insights and technical background on our rHSA. […]
Successful production of recombinant human serum albumin (rHSA) by the BioTech division
ARTES Biotechnology and Basic Pharma are almost there! Our joint project for the production of recombinant human serum albumin (rHSA) is nearing completion and the first product is expected to be available this summer. Basic Pharma is well established in the development, production, and licensing of (bio)pharmaceutical products and is now entering the biotech market […]
Basic Pharma consolidates services in pharma and biotech product development and manufacturing
Behind the scenes, we have been busy streamlining and consolidating our service offering to provide a clear snapshot of our capabilities for our customers. The first change you’ll notice is a fresh new look and restructured website – feel free to explore further and check it out! Our pharmaceutical services are available as a complete […]
